Kir6.2, diabetes and neurology: new insights, new diagnosis and new treatment

被引：0
|
作者：
Slingerland, Annabelle S.
Nuboer, R.
Hadders Algra, Mijna
Hattersley, Andrew T.
Bruining, G. Jan
机构：
[1] Inst Biomed &Clin Sci, Exeter, Devon, England
[2] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands
[3] Meander Med Ctr, Amersfoort, Netherlands
[4] Univ Groningen, Med Ctr, Dept Neurodev, Groningen, Netherlands
[5] Erasmus Med Ctr Rotterdam, Dept Diabet, Rotterdam, Netherlands
来源：
HORMONE RESEARCH | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [1] Mutations in the Kir6.2 subunit of the KATP channel and permanent neonatal diabetes:: New insights and new treatment
    Slingerland, AS
    Hattersley, AT
    ANNALS OF MEDICINE, 2005, 37 (03) : 186 - 195
  • [2] Activating mutations in Kir6.2 and neonatal diabetes - New clinical syndromes, new scientific insights, and new therapy
    Hattersley, AT
    Ashcroft, FM
    DIABETES, 2005, 54 (09) : 2503 - 2513
  • [3] Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions
    Tammaro, P
    Girard, C
    Molnes, J
    Njolstad, PR
    Ashcroft, FM
    EMBO JOURNAL, 2005, 24 (13): : 2318 - 2330
  • [4] Successful oral sulfonylurea treatment for diabetes caused by Kir6.2 mutations
    不详
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 (12): : 652 - 653
  • [5] Identification of activators of the KIR6.2/SUR1 type of KATP channels, new drug candidates for treatment of type 2 diabetes.
    Hansen, JB
    Nielsen, FE
    Tagmose, TM
    Hansen, HC
    Arkhammar, POG
    Boonen, HCM
    Worsaae, A
    Wahl, P
    Bodvarsdottir, T
    Sturis, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U177 - U177
  • [6] Neonatal diabetes -: The role of KCNJ11 (Kir6.2)
    Tammaro, Paolo
    CONGENITAL ENDOCRINOPATHIES: NEW INSIGHTS INTO ENDOCRINE DISEASES AND DIABETES, 2007, 11 : 70 - 82
  • [7] Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2
    Zung, A
    Glaser, B
    Nimri, R
    Zadik, Z
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11): : 5504 - 5507
  • [8] SUR1/Kir6.2 potassium channel a new actor involved in pulmonary arterial hypertension
    Le Ribeuz, Helene
    Lambert, Melanie
    Boet, Angele
    Montani, David
    Chung, Wendy K.
    Humbert, Marc
    Antigny, Fabrice
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [9] Sur1/kir6.2 Potassium Channel a New Actor Involved in Pulmonary Arterial Hypertension
    Le Ribeuz, Helene
    Boet, Angele
    Lambert, Melanie
    Chung, Wendy K.
    Montani, David
    Humbert, Marc
    Antigny, Fabrice
    CIRCULATION, 2019, 140
  • [10] An In-Frame Deletion in Kir6.2 (KCNJ11) Causing Neonatal Diabetes Reveals a Site of Interaction between Kir6.2 and SUR1
    Craig, Tim J.
    Shimomura, Kenju
    Holl, Reinhard W.
    Flanagan, Sarah E.
    Ellard, Sian
    Ashcroft, Frances M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (07): : 2551 - 2557
12345